Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
Public ClinicalTrials.gov record NCT00375193. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Trial of Single-Agent Amrubicin in Patients With Extensive Disease Small Cell Lung Cancer That is Refractory or Progressive Within 90 Days of Completion of First Line Platinum-based Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the objective tumor response rate of amrubicin when administered as second-line therapy to ED-SCLC patients who have refractory or progressive disease.
Study identification
- NCT ID
- NCT00375193
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2006 (Actual)
- Primary completion
- May 1, 2008 (Actual)
- Completion
- Mar 1, 2009 (Actual)
- Last update posted
- Oct 24, 2019
2006 – 2009
United States locations
- U.S. sites
- 44
- U.S. states
- 20
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hematology Oncology Associates | Phoenix | Arizona | 85012 | — |
| Rocky Mountain Cancer Center - Sky Ridge | Lone Tree | Colorado | 80124 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Cancer Centers of Florida, PA | Ocoee | Florida | 34761 | — |
| John B. Amos Cancer Center | Columbus | Georgia | 31904 | — |
| Cancer Care & Hematology Specialists of Chicago | Niles | Illinois | 60714 | — |
| Oncology & Hematology of Central Illinois | Peoria | Illinois | 61602 | — |
| Blessing Cancer Center | Quincy | Illinois | 62301 | — |
| Central Indiana Cancer Centers - Indianapolis | Indianapolis | Indiana | 46227 | — |
| Norton Healthcare - Louisville Oncology | Louisville | Kentucky | 40202 | — |
| Maryland Oncology Hematology, PA | Columbia | Maryland | 21044 | — |
| Alliance Hematology Oncology, PA - Carroll County Cancer Center | Westminster | Maryland | 21157 | — |
| West Michigan Cancer Center | Kalamazoo | Michigan | 49007 | — |
| Minnesota Onc/Hem, PA - Minneapolis | Minneapolis | Minnesota | 55404 | — |
| University of MN/Division of Hematology, Oncology & Transplantation | Minneapolis | Minnesota | 55455 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| St. Joseph Oncology, Inc. | Saint Joseph | Missouri | 64507 | — |
| Arch Medical Group - Arch Medical Services, Inc. | St Louis | Missouri | 63141 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89109 | — |
| New York Oncology Hematology, PC | Albany | New York | 12208 | — |
| SUNY Upstate Medical Center | Syracuse | New York | 13210 | — |
| Northwestern Carolina Oncology & Hematology | Hickory | North Carolina | 28602 | — |
| Raleigh Hematology Oncology Associates | Raleigh | North Carolina | 27607 | — |
| Willamette Valley Cancer Center | Eugene | Oregon | 97401 | — |
| Medical Oncology Associates | Kingston | Pennsylvania | 18704 | — |
| University of Tennessee Medical Center, Knoxville | Knoxville | Tennessee | 37920 | — |
| Sarah Cannon | Nashville | Tennessee | 37203 | — |
| Texas Oncology - Amarillo | Amarillo | Texas | 79106 | — |
| Mamie McFaddin Ward Cancer Center | Beaumont | Texas | 77702-1449 | — |
| Texas Oncology, PA - Bedford | Bedford | Texas | 76022 | — |
| Texas Cancer Center at Medical City | Dallas | Texas | 75230-2510 | — |
| Texas Oncology, P.A. - Dallas | Dallas | Texas | 75246 | — |
| Texas Oncology, P.A., Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology, PA - Fort Worth | Fort Worth | Texas | 76104 | — |
| West Texas Cancer Center | Odessa | Texas | 79761 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texas Oncology Cancer Care and Research Center | Waco | Texas | 76712 | — |
| Texas Oncology, PA - Deke Slayton Cancer Center | Webster | Texas | 77598 | — |
| Texas Oncology - Wichita Falls | Wichita Falls | Texas | 76310 | — |
| Virginia Oncology Associates - Norfolk, VA | Norfolk | Virginia | 23502 | — |
| Oncology & Hematology Associates of Southwest Virginia, Inc. | Salem | Virginia | 24153 | — |
| Puget Sound Cancer Center | Seattle | Washington | 98133 | — |
| Northwest Cancer Specialists - Vancouver Cancer Center | Vancouver | Washington | 98684 | — |
| Yakima Regional Cancer Care Center - North Star Lodge Cancer Center | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00375193, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 24, 2019 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00375193 live on ClinicalTrials.gov.